Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fresh frozen plasma versus Omniplasma coagulation study in pediatric cardiac surgery
2021-000444-22Phase 4Active
- Sponsor
- Erasmus MC
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of octaplas lg and fresh-frozen plasma in coagulation defects and Cardiovascular Malformation (CVM) (2 arms), sponsored by Erasmus MC. Primary endpoint: Difference in coagulation variables immediately after surgery. Started Mar 2021; status: active.
02
Drugs
octaplas lgfresh-frozen plasma
03
Conditions
coagulation defectsCardiovascular Malformation (CVM)
Beyond the preview
Go deeper on 2021-000444-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000444-22.